Collaborations in EU Funded RampD Programmes Célia Gavaud Pera Consulting UK Ltd Chair Pera EEMEA Pera EEMEA is part of Pera Consulting UK Ltd Since 1946 Pera has Delivered ID: 791386
Download The PPT/PDF document "5th Panel – University – Industry" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
5th Panel – University – Industry Collaborations in EU Funded R&D Programmes
Célia Gavaud
Pera Consulting (UK) Ltd.
Chair
Slide2Pera EEMEAPera EEMEA is part of Pera Consulting (UK) Ltd. Since 1946, Pera has Delivered economic development & business support programmes around the world With a proven track record of providing
returns on investment of over 20:1EC programmes for R&D (FPs or
H2020): our collective knowledge, tools and methodologies have been translated into a series of training, mentoring and support programmesRecently
awarded the H2020 CBTT project
PROGRESS-TT will start 01/01/2015 to support TTOs
across EU
Slide3PanelDr Ian McKay, PhD, R&D IP expert, Leicester (UK)Lidia Aguilera, Knowledge Transfer Manager, KIM Bcn, Luxembourg (L)Dr Poul de Haan, Senior IP Counsel, Philips Intellectual Property & Standards, Eindhoven (NL)
Massimiliano Granieri, Vice-President MITO Tech, Milan (I)
Slide4University – Industry Collaborations in EU Funded R&D ProgrammesH2020 offers huge opportunities for collaboration between universities and industry However to turn this into commercial
success, project coordinators and partners must learn how to navigate that particular context of IP exploitationIn
this panel, experts will illustrate this issue from various points of view: researchers, SMEs, Large Enterprises; during and after the EC project
Slide5University-Industry collaboration– EC R&D projects: an asset for commercialisation? What happens IP-wise when partners collaborate beyond national boundaries? What does the EC expects in terms of IP exploitation? Why is IP protection important to the EC? The “open innovation model” is often promoted by the EC; but what does it mean for the academic partners?
How to manage partners’ expectations regarding IP & exploitation?Why is IP exploitation/protection
often a problem in SME projects? How can this be resolved? How is it different from the point of view of
a Large Enterprise?How does an LE leverage FP/H2020 for IP exploitation?How
does an LE manage the collaboration with other partners especially SMEs? How can consortia successfully manage IP after the end of
the EC project?How to ensure the project results really get to the markets?Universities created IP, what’s their responsibility to the consortium?